Pharmaceutical companies and the UNITAID patent pool

At a recent panel discussion, the Department for International Development's Parliamentary Undersecretary of State, Mike Foster, asked pharmaceutical companies to work with UNITAID on the Pool design-a request several com panies have already fulfi lled-and GlaxoSmithKline's president of em...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2010-01, Vol.375 (9708), p.30-30
Main Author: Hoen, Ellen ‘t
Format: Article
Language:English
Subjects:
Acquired Immunodeficiency Syndrome - drug therapy
Drug Industry
Emerging markets
Humans
Internal Medicine
Patents as Topic - legislation & jurisprudence
Pharmaceutical industry
United Kingdom
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At a recent panel discussion, the Department for International Development's Parliamentary Undersecretary of State, Mike Foster, asked pharmaceutical companies to work with UNITAID on the Pool design-a request several com panies have already fulfi lled-and GlaxoSmithKline's president of emerging markets, Abbas Hussein, told the audience he was "very, very supportive of the UNITAID patent pool."
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(09)62189-9